The DNA of the first northcentral United States human Lyme disease isolate, Borrelia burgdorferi NCH-1, was characterized and compared with the DNAs of nine other B. burgdorferi isolates. Strain NCH-1 was isolated in August 1989 from a human skin biopsy specimen. DNA was analyzed by pulsed-field gel electrophoresis and restriction endonuclease analysis. Contour-clamped homogeneous electric field pulsed-field gel electrophoresis of in situ-lysed cells was performed to compare the plasmid profiles of the various isolates. The plasmid profile of isolate NCH-1, which included five plasmids of approximately 69, 42, 38, 32 , and 23 kb, could be distinguished from those of the other isolates examined. The DNA profile of NCH-1 was most similar to those of strain 297 (human cerebrospinal fluid isolate, Connecticut) and strain PAL (human erythema migrans isolate, New York) and most dissimilar from those of strain P/Gau (human erythema migrans isolate, Germany) and strain IPF (Ixodes persulcatus tick isolate, Japan Although Lyme disease spirochetes have been isolated from blood (7, 21, 33), cerebrospinal fluid (22, 34), synovial fluid (26), and biopsy specimens of skin lesions of erythema migrans and acrodermatitis chronicum atrophicans (2, 8, 23, 33) , the frequency of recovery of B. burgdorfen from Lyme disease patient specimens is low. To date, most human isolates in the United States have been recovered from patients in the northeast, where the disease is most prevalent. Although B. burgdorferi has been isolated from animals and ticks in the northcentral United States, the isolation of B. burgdorferi from a human specimen has not been reported. This report characterizes the DNA of the first northcentral U.S. human Lyme disease isolate, B. burgdorferi NCH-1. Restriction endonuclease analysis. Isolated DNA was digested with the restriction endonucleases BamHI, EcoRI, HindIII, DpnI, MboI, and Sau3AI in accordance with the manufacturers' directions (Boehringer Mannheim Corp., Biochemical Products, Indianapolis, Ind., and GIBCO BRL, Life Technologies, Inc., Gaithersburg, Md.). Following digestion, the DNA fragments were separated by electrophoresis in agarose gels. Lambda DNAs digested with HindIII served as size markers. The gels were stained with ethidium bromide, illuminated with UV light, and photographed.
rodents, raccoons, dogs, horses, cattle, and birds. B. burgdorferi has also been isolated from Lxodes sp. ticks (see reference 4 for a review).
Although Lyme disease spirochetes have been isolated from blood (7, 21, 33) , cerebrospinal fluid (22, 34) , synovial fluid (26) , and biopsy specimens of skin lesions of erythema migrans and acrodermatitis chronicum atrophicans (2, 8, 23, 33) , the frequency of recovery of B. burgdorfen from Lyme disease patient specimens is low. To date, most human isolates in the United States have been recovered from patients in the northeast, where the disease is most prevalent. Although B. burgdorferi has been isolated from animals and ticks in the northcentral United States, the isolation of B. burgdorferi from a human specimen has not been reported. This report characterizes the DNA of the first northcentral U.S. human Lyme disease isolate, B. burgdorferi NCH-1.
MATERILLS AND METHODS
Isolation of NCH-1. NCH-1 was isolated in our laboratory in August 1989 from a human skin biopsy specimen obtained from a patient in Wisconsin. The Inc ., Walkersville, Md.). Under sterile conditions, a 4-mm punch biopsy specimen from the peripheral margin of an erythema migrans lesion was obtained for culturing in Barbour-Stoenner-Kelly medium (3) at 30°C. The patient was treated with doxycycline (100 mg twice a day for 21 days), the rash resolved, and the patient's general health and well-being returned to normal.
The spirochete was isolated from the biopsy culture and determined to be virulent in our hamster model (14) . The organism was also examined by an immunofluorescence assay with a panel of murine monoclonal antibodies (10) . These monoclonal antibodies included NYS-llGl (provided by the New York Department of Health, Stony Brook), which recognizes OspA protein; H5332 and H3TS, which recognize OspA protein; and H9724, which recognizes the flagellin protein (the last three antibodies were provided by Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Mont.).
Other strains and cultivation. The biographical and geographical origins of the strains used in this study are shown in Table 1 . B. burgdorferi strains were cultured in BarbourStoenner-Kelly medium at 30'C. Strains were cultured no more than 10 times from the original isolation, with the exception of strains B31 and 297, which were maintained from stock cultures.
DNA isolation. Total (genomic) DNA was isolated as previously described (11) .
Moles percent G+C content. Moles percent G+C content analysis by the method of Marmur and Doty (19) was done on DNA isolated from selected B. burgdorferi strains. Thermal denaturation curves were generated by use of a Gilford Response spectrophotometer with thermal programming (Ciba-Corning Diagnostics Corp., Medfield, Mass.), and the denaturation temperature (Tm) was determined for each strain from the results of at least three separate experiments PFGE. An LKB 2015 Pulsaphor system (Pharmacia LKB Biotechnology, Uppsala, Sweden) equipped with a contourclamped homogeneous electric field (CHEF) electrode was used in pulsed-field gel electrophoresis (PFGE) experiments. DNA from B. burgdorferi was prepared by the gel insert method (30) . In brief, B. burgdorferi grown in BarbourStoenner-Kelly medium to the stationary phase (approximately 1 week) was collected by centrifugation and washed in 10 mM Tris-HCl (pH 7.6)-i M NaCl. The cell pellet was thoroughly resuspended in 10 mM Tris-HCI (pH 7.6)-i M NaCl at a concentration of about 109 cells per ml, and the suspension was warmed to 37°C, mixed with an equal volume of 1% low-gelling-temperature agarose, and distributed to insert molds. The molds were cooled at -20°C for 5 min to allow the agarose to solidify, and the inserts were pushed out of the molds with a bent glass Pasteur pipet into lysis solution (6 mM Tris-HCl [pH 7.6], 1 M NaCl, 100 mM EDTA, 0.5% Brij-58, 0.2% deoxycholate, 0.5% Sarkosyl, 20 ,Ig of DNase-free RNase per ml, 1 mg of lysozyme per ml). The samples were incubated overnight at 37°C with gentle shaking. The solution was changed to 0.5 M EDTA (pH 9 to 9.5)-1% sodium lauroyl sarcosine-2 mg of proteinase K per ml, and the inserts were incubated for an additional 2 Total (genomic) DNAs were isolated from the 10 test strains, and the moles percent G+C contents were determined ( Table 2 ). The Tm for NCH-1 was determined to be 81.36°C. The Tms for the other'strains were not found to be significantly different. On the basis of these determinations, the moles percent G+C content of NCH-1 was calculated to be 29.4, similar to those calculated for the other' strains studied. These results are in concordance with those for other B. burgdorfeni strains (13) .
The DNAs from these strains were also examined for the presence of methylated adenine residues. The DNAs were incubated with restriction endonucleases DpnI, MboI, and Sau3AI. The DNA of strain NCH-1 was not digested with DpnI, which recognizes GATC sequences with methylated adenine residues, suggesting that this strain lacks an adenine methylation system ( gested with Sau3AI, which recognizes both methylated and unmethylated GATC sequences. B31, the type strain of the species, and strains 297, MMT1, CT-1, IPS, and P/Bi also lacked methylated adenine residues. In contrast, strains PAL (New York, skin), IPF (Japan, tick), and P/Gau (Germany, skin) were found to contain methylated DNA. In situ-lysed DNA samples from each strain were analyzed by CHEF PFGE to determine plasmid content (Fig. 1 (Fig. 2) . The NCH-1 genomic DNA probe recognized all NCH-1 plasmids in addition to all of the plasmids in strains B31, 297, PAL, and IPS; four of five plasmids in strains MMT1, CT-1, P/Gau, and P/Bi; and three of five plasmids in strain IPF. The 23.6-kb plasmid of NCH-1, which was in proportionately lower quantity than the other plasmids ( Fig. 1) , was recognized by the NCH-1 genomic DNA probe (Fig. 2, arrow) . The NCH-1 genomic DNA probe did not appear to hybridize with the 36-kb plasmid of P/Bi or the 33-kb plasmid of IPF and only weakly hybridized under these conditions with the 52-kb-plasmid of P/Gau, the 50-kb plasmid of IPF, the 33-kb plasmid of MMT1, and the 30-kb plasmid of CT-1. DNAs isolated from these strains were also compared by restriction endonuclease analysis (Fig. 3) . The electrophoretic pattern following HindIII digestion is shown in Fig. 3A . Similarities were observed among the patterns of NCH-1, 297, B31, and IPS, especially in the lower portions of the gel, in the 4.4-to 2.0-kb range. The results of BamHI digestion are shown in Fig. 3B . Similarities among the NCH-1 pattern and those of MMT1 and CT-1, two other northcentral U.S. strains, were evident, especially in the 9.4-to 4.4-kb range. The BamHI digestion patterns of P/Gau and P/Bi (Germany) and IPF (Japan) were very different from that of NCH-1. Finally, when NCH-1 DNA was digested with EcoRI, the resulting pattern was very similar to the EcoRI digestion patterns of the other U.S. strains: 297, B31, IPS, MMT1, CT-1, and PAL (Fig. 3C) . The EcoRI digestion patterns of the European strains, P/Gau and P/Bi, appeared to be similar to each other but were distantly related to those of strain NCH-1 and the other U.S. strains. The EcoRI banding pattern of the Japanese strain, IPF, was distinctly different from those of strain NCH-1 and the other strains compared in this study. DISCUSSION This study was undertaken to characterize and compare the DNA of the first northcentral U.S. human Lyme disease isolate with those of nine other B. burgdorferi isolates. NCH-1 was isolated from a biopsy specimen obtained from the peripheral margin of a lesion from a patient who had presented with multiple erythema migrans lesions. NCH (17) . Others have determined plasmid profiles for isolates of B. burgdorferi; however, their methods involved isolation and purification of DNA followed by separation of DNA components by low-percentage-agarose gel electrophoresis (5, 27, 29) , CHEF PFGE (6), or field inversion gel electrophoresis (32) . In studies which compared strain B31 with other strains (5, 17, 27, 32) , B31 was observed to contain four plasmids. We were also able to discern four plasmids in in situ-lysed preparations of strain B31 separated by PFGE. However, direct comparisons with previously published results were difficult, as the sizes of the plasmids varied with the methods used for their preparation, separation, and characterization. Nonetheless, plasmid profiles are useful in the characterization of Borrelia DNA, especially when determined following in situ lysis and PFGE.
The results of PFGE and hybridization with NCH-1 DNA demonstrate that homology exists in both the chromosomes and some of the plasmids of the isolates studied. The hybridization results together with the restriction endonuclease analysis results indicate that strain NCH-1 appears to be more closely related genetically to strains B31, 297, and IPS (U.S. isolates) than to the European strains, P/Gau and P/Bi, or the Asian strain, IPF. The restriction endonuclease patterns observed support the usefulness of restriction endonuclease analysis in the classification of B. burgdorfen isolates (18) . These results confirm that genetic diversity exists among B. burgdorfeni strains isolated from different geographical areas, as reported by others (1, 5, 17, 18) .
